15
Participants
Start Date
September 30, 2012
Primary Completion Date
September 30, 2013
Study Completion Date
January 31, 2014
Panobinostat
20 mg panobinostat will be administered orally on days 1, 3, and 5 (TIW) every other week (QOW) for a period of 8 weeks while maintaining background HAART
Department of Infectious Diseases, Aarhus University Hospital, Aarhus
Collaborators (1)
Massachusetts General Hospital
OTHER
Monash University
OTHER
University of Sydney
OTHER
Novartis
INDUSTRY
Aarhus University Hospital
OTHER
University of Aarhus
OTHER